May 10, 2016
UC San Diego Clinical and Translational Research Institute (CTRI) is pleased to announce that Murray B. Stein, MD, MPH has been named co-director of the Translational Research Alliance (TRA). Stein, a Distinguished Professor of Psychiatry and Family Medicine and Public Health at UC San Diego, will also join the CTRI Executive Committee. Dr. Stein has successfully led the CTRI Pilot Project Program since 2012, and will continue to oversee the program.
“We are delighted Dr. Stein is joining the leadership of the CTRI,” said Gary S. Firestein, MD, director of the CTRI. “As head of our pilot project program, he has demonstrated remarkable strength in helping us create infrastructures that facilitate collaboration and actively bring various groups together.”
The CTRI established the TRA as a coordinating entity to develop new pathways for clinical investigators to collaborate with basic science researchers outside UC San Diego and to provide new tools for basic scientists across the San Diego region to translate discoveries into new treatments. Dr. Stein will co-direct TRA with Deborah Spector, PhD. He also serves as the faculty lead for the UC Cures for Alzheimer’s Initiative RFA launched earlier this year by the University of California.
“I look forward to continuing to work with Dr. Spector to co-direct the Translational Research Alliance and assist her in expanding its outreach and utility to UC San Diego and our research partners,” Dr. Stein said.
Dr. Stein is also a staff psychiatrist at the VA San Diego Healthcare System. He graduated from the University of Manitoba and completed his residency and post-residency fellowship at the University of Manitoba, the University of Toronto and at the National Institute of Mental Health in Bethesda, Maryland. He subsequently completed a master of public health degree at the Johns Hopkins University Bloomberg School of Public Health in Baltimore.
Dr. Stein’s research interests include the epidemiology, neurobiology, and treatment of anxiety and trauma-related disorders, especially social phobia, panic disorder, and post-traumatic stress disorder. He has written or co-written over 550 peer-reviewed scientific articles on these topics, including in journals such as Journal of the American Medical Association, New England Journal of Medicine, The Lancet, American Journal of Psychiatry, and JAMA Psychiatry. His federally funded research has included studies of interventions for anxiety disorders in primary care, pharmacological approaches to treatment-resistant anxiety and stress-related disorders, and functional neuroimaging research in anxiety and trauma-related disorders. Dr. Stein is Co-Editor-in-Chief for UpToDate in Psychiatry, and Deputy Editor for the journal Biological Psychiatry. He is a member of the Scientific Advisory Board of the Anxiety and Depression Association of America (ADAA) and the Brain and Behavior Research Foundation (BBRF), and a Fellow of the American College of Neuropsychopharmacology (ACNP).
About UC San Diego Altman Clinical and Translational Research Institute:
UC San Diego Altman Clinical and Translational Research Institute (ACTRI) is part of a national Clinical and Translational Science Award consortium, led by the National Institutes of Health National Center for Advancing Translational Science. Established in 2010, ACTRI provides infrastructure and support for basic, translational and clinical research throughout the San Diego region to bring discoveries from the laboratory to the bedside, and facilitates training and education of the next generation of researchers. ACTRI carries out its activities in collaboration with institutional and corporate partners and currently has more than 1,500 members.